Afya Limited (NASDAQ:AFYA) Stock Has Consensus Price Target of $17.25

Afya Limited (NASDAQ:AFYA – Get Free Report) has earned an average recommendation of “Hold” from the seven analysts that are presently covering the stock, MarketBeat.com reports. Five equities research analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $17.25.

A number of research firms have commented on AFYA. Bradesco Corretora upgraded shares of Afya to an “outperform” rating and set a $17.00 price target on the stock in a research report on Thursday, September 24th. JPMorgan Chase & Co. upgraded shares of Afya from a “neutral” rating to an “overweight” rating and decreased their price objective for the company from $21.00 to $19.00 in a report on Wednesday, October 7th. Wall Street Zen upgraded shares of Afya from a “hold” rating to a “buy” rating in a research note on Saturday, September 5th. Zacks Research upgraded shares of Afya from a “strong sell” rating to a “hold” rating in a research note on Monday, October 5th. Finally, Weiss Ratings cut Afya from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday, July 31st.

View Our Latest Stock Report on Afya

Afya Price Performance

Shares of AFYA opened at $10.64 on Tuesday. Afya has a one year low of $10.05 and a one year high of $16.16. The stock’s fifty day moving average is $13.96 and its 200-day moving average is $14.31. The company has a debt-to-equity ratio of 0.39, a quick ratio of 2.20 and a current ratio of 2.20. The firm has a market capitalization of $997.18 million, a price-to-earnings ratio of 6.49, a price-to-earnings-growth ratio of 1.83 and a beta of 0.34.

Afya (NASDAQ:AFYA – Get Free Report) last posted its quarterly earnings data on Friday, August 14th. The company reported $0.43 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.03. The business had revenue of $187.80 million during the quarter, compared to the consensus estimate of $189.62 million. Afya had a net margin of 20.55% and a return on equity of 17.58%. Equities analysts anticipate that Afya will post 1.72 EPS for the current year.

Insider Transactions at Afya

In other Afya news, insider Santos Welder Ferreira sold 4,161 shares of the stock in a transaction on Monday, October 5th. The stock was sold at an average price of $13.30, for a total transaction of $55,341.30. Following the completion of the transaction, the insider directly owned 35,000 shares of the company’s stock, valued at approximately $465,500. This trade represents a 10.63% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Institutional Trading of Afya

A hedge fund recently bought a new stake in Afya stock. Engineers Gate Manager LP bought a new stake in shares of Afya Limited (NASDAQ:AFYA – Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 21,882 shares of the company’s stock, valued at approximately $325,000. Institutional investors and hedge funds own 88.02% of the company’s stock.

About Afya

(Get Free Report)

Afya Limited is a medical education and digital health company focused on Brazil. Through its educational platform, the company provides undergraduate medical education, medical residency preparation, specialization and continuing medical education programs, and other learning resources for students and physicians.

Afya also offers digital products and services intended to support healthcare professionals throughout their careers. These include clinical content, study tools, telemedicine and practice-management solutions, and subscription-based applications designed to assist physicians with education, clinical decision-making, and patient care.

The company has expanded through the development and acquisition of medical schools, education businesses, and health technology platforms serving different stages of the medical professional lifecycle.

See Also

Analyst Recommendations for Afya (NASDAQ:AFYA)

Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.